AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "Food and Drug Administration"

FDA Invites Comments on Proposal to Revise Lifetime Deferral on Blood Donation by Gay Men

FDA

In a Federal Register notice published Friday, May 15, 2015, the Food and Drug Administration (FDA) is inviting public comments on the following draft recommendations: Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products [PDF 135KB]. This draft guidance, to establishments that collect blood or blood components, proposes…

New Hepatitis C Treatments Have High Cure Rates for African Americans

CDC heptatis image AfricanAm-186x260

The epidemic of chronic hepatitis C virus (HCV) infection impacts over 3 million individuals in the United States, and over 50% of infected people are undiagnosed. In an effort to increase the number of people who are aware of their HCV infection and link them to care, in 2012 the U.S. Centers for Disease Control…

Medicare Announces Coverage for Annual HIV Test

CMS Logo

The Centers for Medicare and Medicaid Services (CMS) announced this week that it has expanded coverage to include one, annual voluntary screening for HIV infection for all adolescent and adult Medicare beneficiaries between the ages of 15 and 65, without regard to perceived risk.  Coverage for pregnant Medicare beneficiaries will remain unchanged. The addition of…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection….

Free AIDSinfo Drug App: HIV-Related Drug Information for Health Care Providers and Consumers

AIDS info logo

Healthcare providers and consumers need HIV-related drug information and, increasingly, they depend on mobile devices to access that information. AIDSinfo is meeting both needs with the release of the AIDSinfo Drug App. Using data from the AIDSinfo Drug Database, the drug app provides information on more than 100 HIV-related Food and Drug Administration (FDA)-approved and…

The HIV Test at 30: More Essential Than Ever

unnamed

Early in the AIDS epidemic, there was so much we didn’t know — what caused the disease, how it was spread or how to treat it. But, once scientists were able to isolate and establish a virus — HIV — as the cause of AIDS, that all began to change. For one thing, knowing what…

A Post from the ADAP Crisis Task Force

AIDS.gov

ADAP Crisis Task Force Announces Groundbreaking Agreement with AbbVie for Hepatitis C Treatment Viekira Pak ™ FOR IMMEDIATE RELEASE Contact:  Britten Pund 202-434-8090 bpund@NASTAD.org  January 15, 2015, Washington, DC – The ADAP Crisis Task Force (Task Force) has reached a new pricing agreement between AbbVie and AIDS Drug Assistance Programs (ADAPs) for Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets;…